ABSTRAn. There are few published data regarding the circulatory effects of systemic epinephrine infusions in newborn subjects. We therefore instrumented six piglets aged 5 to 10 d while they were under pentobarbitone anesthesia for determination of cardiac output, left anterior descending coronary artery flow, systemic and pulmonary pressures, and mixed venous, arterial and coronary sinus gases. Systemic, coronary, and pulmonary vascular resistances, coronary oxygen consumption, and myocardial oxygen extraction ratio were calculated. Epinephrine was infused at doses from 0.2 to 3.2 pg/kg/min doubling at 15-min intervals, and measurements were taken after stability had been obtained. Cardiac o u t~u t increased at the lowest dose investigated, i.e. 0.2 pg/kg/min, and progressively increased as the dose was advanced up to 1.6 pglkglrnin, decreasing significantly at 3.2 pg/kg/min. Blood increased progressively, being significantly above baseline at 0.8, 1.6, and 3.2 pg/kg/min and having increased by approximately 81% at the highest dose investigated. Pulmonary arterial pressures were also increased at 1.6 and 3.2 pg/kg/min, but only by 35% at the highest dose of 3.2 pg/kg/min. Systemic and pulmonary vascular resistances both decreased at the three lower doses investigated and then began to increase progressively; however, the systemic vascular resistance increased to a significantly greater degree than pulmonary vascular resistance. Coronary oxygen consumption increased progressively as the epinephrine dose was increased; however, coronary blood flow and coronary oxygen delivery increased more than oxygen consumption, leading to a progressive reduction in myocardial oxygen extraction ratio and a progressive increase in coronary sinus oxygen content. Whole-body oxygen consumption was increased, but to a lesser extent than systemic oxygen transport. We conclude that, at low doses, epinephrine is a potent inotrope and a systemic and pulmonary vasodilator in the newborn piglet. With progressive increases in the dose, systemic vasoconstriction is significantly greater than pulmonary. Increasing cardiac oxygen demands are oversupplied by increases in coronary blood flow. fusions are occasionally used as a back-up inotropic therapy for sick newborn infants (l), particularly those with persistent pulmonary hypertension of the newborn. In such infants, pulmonary vascular resistance is elevated and cardiac output is low (2). A drug that has selective pulmonary vasodilating or selective systemic pressor and positive inotropic properties would therefore be of great value. One previous study of the effects of highdose epinephrine infusions (3.5, 7, and 15 pg/kg/min) (3) in newborn piglets with group B streptococcus-induced pulmonary hypertension suggested a selective systemic pressor effect. To obtain additional information regarding the effects of this mode of therapy, the following study was performed to determine the effects of epinephrine infusions at lower, clinically applicable doses in healthy, acutely instrumented pigle...